PTPN11 and cancer: This study provides critical molecular insights for the development of efficient SHP2-targeted inhibitors and deepens the understanding of SHP2’s pivotal role in disease-related signaling and pathological mechanisms, thereby laying a solid foundation for precision therapeutic strategies in cancer and other SHP2-associated diseases.